{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T18:41:53Z","timestamp":1788028913774,"version":"build-2784847793"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T00:00:00Z","timestamp":1549497600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Fund of China","doi-asserted-by":"crossref","award":["81770380"],"award-info":[{"award-number":["81770380"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13023-019-1010-z","type":"journal-article","created":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T08:06:27Z","timestamp":1549526787000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Clinical and mutation profile of pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: results from a Chinese cohort"],"prefix":"10.1186","volume":"14","author":[{"given":"Hao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoliang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meirong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiumin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,7]]},"reference":[{"key":"1010_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0140-6736(12)61023-X","volume":"381","author":"AE Roberts","year":"2013","unstructured":"Roberts AE, Allanson JE, Tartaglia M, Gelb BD. Noonan syndrome. Lancet. 2013;381:333\u201342.","journal-title":"Lancet"},{"key":"1010_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ppedcard.2015.01.002","volume":"39","author":"BD Gelb","year":"2015","unstructured":"Gelb BD, Roberts AE, Tartaglia M. Cardiomyopathies in Noonan syndrome and the other RASopathies. Prog Pediatr Cardiol. 2015;39:13\u20139.","journal-title":"Prog Pediatr Cardiol"},{"key":"1010_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/jhg.2015.114","volume":"61","author":"Y Aoki","year":"2016","unstructured":"Aoki Y, Niihori T, Inoue S, Matsubara Y. Recent advances in RASopathies. J Hum Genet. 2016;61:33\u20139.","journal-title":"J Hum Genet"},{"key":"1010_CR4","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1542\/peds.2006-0163","volume":"118","author":"GF Cox","year":"2006","unstructured":"Cox GF, Sleeper LA, Lowe AM, Towbin JA, Colan SD, Orav EJ, et al. Factors associated with establishing a causal diagnosis for children with cardiomyopathy. Pediatrics. 2006;118:1519\u201331.","journal-title":"Pediatrics"},{"key":"1010_CR5","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1161\/CIRCULATIONAHA.104.530303","volume":"112","author":"AW Nugent","year":"2005","unstructured":"Nugent AW, Daubeney PE, Chondros P, Carlin JB, Colan SD, Cheung M, et al. Clinical features and outcomes of childhood hypertrophic cardiomyopathy: results from a national population-based study. Circulation. 2005;112:1332\u20138.","journal-title":"Circulation"},{"issue":"Suppl","key":"1010_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1067\/mhj.2000.103933","volume":"139","author":"MA Grenier","year":"2000","unstructured":"Grenier MA, Osganian SK, Cox GF, Towbin JA, Colan SD, Lurie PR, et al. Design and implementation of the North American Pediatric Cardiomyopathy Registry. Am Heart J. 2000;139(Suppl):86\u201395.","journal-title":"Am Heart J"},{"key":"1010_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"1010_CR8","doi-asserted-by":"publisher","first-page":"6785","DOI":"10.1074\/jbc.M513068200","volume":"281","author":"MI Kontaridis","year":"2006","unstructured":"Kontaridis MI, Swanson KD, David FS, Barford D, Neel BG. PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects. J Biol Chem. 2006;281:6785\u201392.","journal-title":"J Biol Chem"},{"key":"1010_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1750-1172-3-13","volume":"3","author":"A Sarkozy","year":"2008","unstructured":"Sarkozy A, Digilio MC, Dallapiccola B. Leopard syndrome. Orphanet J Rare Dis. 2008;3:13.","journal-title":"Orphanet J Rare Dis"},{"key":"1010_CR10","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/0002-9343(76)90764-6","volume":"60","author":"DA Voron","year":"1976","unstructured":"Voron DA, Hatfield HH, Kalkhoff RK. Multiple lentigines syndrome. Case report and review of the literature. Am J Med. 1976;60:447\u201356.","journal-title":"Am J Med"},{"key":"1010_CR11","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/humu.23535","volume":"39","author":"O Ceyhan-Birsoy","year":"2018","unstructured":"Ceyhan-Birsoy O, Miatkowski MM, Hynes E, Funke BH, Mason-Suares H. NGS testing for cardiomyopathy: utility of adding RASopathy-associated genes. Hum Mutat. 2018;39:954\u20138.","journal-title":"Hum Mutat"},{"key":"1010_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1749-6632.2010.05790.x","volume":"1214","author":"M Tartaglia","year":"2010","unstructured":"Tartaglia M, Gelb BD. Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanisms. Ann N Y Acad Sci. 2010;1214:99\u2013121.","journal-title":"Ann N Y Acad Sci"},{"key":"1010_CR13","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/ng2073","volume":"39","author":"B Pandit","year":"2007","unstructured":"Pandit B, Sarkozy A, Pennacchio LA, Carta C, Oishi K, Martinelli S, et al. Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat Genet. 2007;39:1007\u201312.","journal-title":"Nat Genet"},{"key":"1010_CR14","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/humu.21187","volume":"31","author":"T Kobayashi","year":"2010","unstructured":"Kobayashi T, Aoki Y, Niihori T, Cave H, Verloes A, Okamoto N, et al. Molecular and clinical analysis of RAF1 in Noonan syndrome and related disorders: dephosphorylation of serine 259 as the essential mechanism for mutant activation. Hum Mutat. 2010;31:284\u201394.","journal-title":"Hum Mutat"},{"key":"1010_CR15","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/ng2078","volume":"39","author":"MA Razzaque","year":"2007","unstructured":"Razzaque MA, Nishizawa T, Komoike Y, Yagi H, Furutani M, Amo R, et al. Germline gain-of-function mutations in RAF1 cause Noonan syndrome. Nat Genet. 2007;39:1013\u20137.","journal-title":"Nat Genet"},{"key":"1010_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00439-015-1627-5","volume":"135","author":"M Yaoita","year":"2016","unstructured":"Yaoita M, Niihori T, Mizuno S, Okamoto N, Hayashi S, Watanabe A, et al. Spectrum of mutations and genotype-phenotype analysis in Noonan syndrome patients with RIT1 mutations. Hum Genet. 2016;135:209\u201322.","journal-title":"Hum Genet"},{"key":"1010_CR17","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/humu.20955","volume":"30","author":"A Sarkozy","year":"2009","unstructured":"Sarkozy A, Carta C, Moretti S, Zampino G, Digilio MC, Pantaleoni F, et al. Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum. Hum Mutat. 2009;30:695\u2013702.","journal-title":"Hum Mutat"},{"key":"1010_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1136\/jmg.2006.046300","volume":"44","author":"M Zenker","year":"2007","unstructured":"Zenker M, Lehmann K, Schulz AL, Barth H, Hansmann D, Koenig R, et al. Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations. J Med Genet. 2007;44:131\u20135.","journal-title":"J Med Genet"},{"key":"1010_CR19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/cvr\/cvt260","volume":"101","author":"MG Dalin","year":"2014","unstructured":"Dalin MG, Zou Z, Scharin-Tang M, Safari R, Karlsson C, Bergo MO. Myocardial KRAS(G12D) expression does not cause cardiomyopathy in mice. Cardiovasc Res. 2014;101:229\u201335.","journal-title":"Cardiovasc Res"},{"key":"1010_CR20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev-genom-091212-153523","volume":"14","author":"KA Rauen","year":"2013","unstructured":"Rauen KA. The RASopathies. Annu Rev Genomics Hum Genet. 2013;14:355\u201369.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"1010_CR21","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/humu.21492","volume":"32","author":"F Lepri","year":"2011","unstructured":"Lepri F, De Luca A, Stella L, Rossi C, Baldassarre G, Pantaleoni F, et al. SOS1 mutations in Noonan syndrome: molecular spectrum, structural insights on pathogenic effects, and genotype-phenotype correlations. Hum Mutat. 2011;32:760\u201372.","journal-title":"Hum Mutat"},{"key":"1010_CR22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/gim.0b013e31822dd91f","volume":"14","author":"KW Gripp","year":"2012","unstructured":"Gripp KW, Lin AE. Costello syndrome: a Ras\/mitogen activated protein kinase pathway syndrome (rasopathy) resulting from HRAS germline mutations. Genet Med. 2012;14:285\u201392.","journal-title":"Genet Med."},{"key":"1010_CR23","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1136\/jmedgenet-2015-103018","volume":"52","author":"GL Yamamoto","year":"2015","unstructured":"Yamamoto GL, Aguena M, Gos M, Hung C, Pilch J, Fahiminiya S, et al. Rare variants in SOS2 and LZTR1 are associated with Noonan syndrome. J Med Genet. 2015;52:413\u201321.","journal-title":"J Med Genet"},{"key":"1010_CR24","doi-asserted-by":"publisher","unstructured":"Johnston JJ, van der Smagt JJ, Rosenfeld JA, Pagnamenta AT, Alswaid A, Baker EH, et al. Autosomal recessive Noonan syndrome associated with biallelic LZTR1 variants. Genet Med. 2018. \n                    https:\/\/doi.org\/10.1038\/gim.2017.249\n                    \n                  .","DOI":"10.1038\/gim.2017.249"},{"key":"1010_CR25","doi-asserted-by":"publisher","unstructured":"Umeki I, Niihori T, Abe T, Kanno SI, Okamoto N, Mizuno S, et al. Delineation of LZTR1 mutation-positive patients with Noonan syndrome and identification of LZTR1 binding to RAF1-PPP1CB complexes. Hum Genet. 2018. \n                    https:\/\/doi.org\/10.1007\/s00439-018-1951-7\n                    \n                  .","DOI":"10.1007\/s00439-018-1951-7"},{"key":"1010_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1747-0803.2010.00465.x","volume":"6","author":"EJ Hickey","year":"2011","unstructured":"Hickey EJ, Mehta R, Elmi M, Asoh K, McCrindle BW, Williams WG, et al. Survival implications: hypertrophic cardiomyopathy in Noonan syndrome. Congenit Heart Dis. 2011;6:41\u20137.","journal-title":"Congenit Heart Dis"},{"key":"1010_CR27","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.ahj.2012.04.018","volume":"164","author":"JD Wilkinson","year":"2012","unstructured":"Wilkinson JD, Lowe AM, Salbert BA, Sleeper LA, Colan SD, Cox GF, et al. Outcomes in children with Noonan syndrome and hypertrophic cardiomyopathy: a study from the pediatric cardiomyopathy registry. Am Heart J. 2012;164:442\u20138.","journal-title":"Am Heart J"},{"key":"1010_CR28","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/ajmg.a.36982","volume":"167a","author":"A Hahn","year":"2015","unstructured":"Hahn A, Lauriol J, Thul J, Behnke-Hall K, Logeswaran T, Schanzer A, et al. Rapidly progressive hypertrophic cardiomyopathy in an infant with Noonan syndrome with multiple lentigines: palliative treatment with a rapamycin analog. Am J Med Genet A. 2015;167a:744\u201351.","journal-title":"Am J Med Genet A"},{"key":"1010_CR29","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00431-005-1679-y","volume":"164","author":"K Takahashi","year":"2005","unstructured":"Takahashi K, Kogaki S, Kurotobi S, Nasuno S, Ohta M, Okabe H, et al. A novel mutation in the PTPN11 gene in a patient with Noonan syndrome and rapidly progressive hypertrophic cardiomyopathy. Eur J Pediatr. 2005;164:497\u2013500.","journal-title":"Eur J Pediatr"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1010-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1010-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1010-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T19:16:18Z","timestamp":1581016578000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1010-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,7]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1010"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1010-z","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,7]]},"assertion":[{"value":"27 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Boards of Shanghai Children\u2019s Medical Center and carried out in accordance with the ethical principles of the Declaration of Helsinki. For gene studies, written informed consents were obtained from the parents.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"29"}}